Authors: Zergeroglu, S Aksakal, O Demirturk, F Gokmen, O

Citation: S. Zergeroglu et al., Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors, GYNECOL OBS, 51(1), 2001, pp. 60-63

Authors: Gokmen, O Ugur, M Ekin, M Keles, G Turan, C Oral, H

Citation: O. Gokmen et al., Intravenous albumin versus hydroxyethyl starch for the prevention of ovarian hyperstimulation in an in-vitro fertilization programme: a prospective randomized placebo controlled study, EUR J OB GY, 96(2), 2001, pp. 187-192

Authors: Out, HJ Braat, DDM Lintsen, BME Gurgan, T Bukulmez, O Gokmen, O Keles, G Caballero, P Gonzalez, JM Fabregues, F Balasch, J Roulier, R

Citation: Hj. Out et al., Increasing the daily dose of recombinant follicle stimulating hormone (Puregon((R))) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation, HUM REPR, 15(1), 2000, pp. 29-35

Authors: Akyol, D Mungan, T Baltaci, V Kozinoglu, H Oguz, S Oztekin, O Gokmen, O

Citation: D. Akyol et al., Clinical assessment of EMA CO induced DNA damage in peripheral blood lymphocytes of high-risk gestational trophoblastic tumor patients, EUR J GYN O, 20(2), 1999, pp. 150-155

Authors: Gokmen, O Eyi, EGY

Citation: O. Gokmen et Egy. Eyi, Hormone replacement therapy and lipid-lipoprotein concentrations, EUR J OB GY, 85(1), 1999, pp. 31-41

Authors: Zeyneloglu, HB Isik, AZ Kara, S Senoz, S Ozcan, U Gokmen, O

Citation: Hb. Zeyneloglu et al., Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization, INT J F W M, 43(6), 1998, pp. 300-305